Work

Turning a blind eye:Why we don't test for blindness at the end of our trials

Year: 2004
Type: letter
Abstract: EDITOR—I write with reference to the paper by Fergusson et al.1 Asking patients or their clinicians at the end of a trial which drug they think they were taking confounds failures in blinding with successes in pre-trial hunches about efficacy. Thirty years ago, at the end of the first ever trial of aspirin and sulfinpyrazone …
Source: BMJ
Language: English
Open Access status: green
OpenAlex ID: W2023797366
Cites: 2
Cited by: 91
Related to: 9